PLUR Logo

Pluri Inc. (PLUR) 

NASDAQ$4.7241
Market Cap
$33.06M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
780 of 924
Rank in Industry
438 of 527

Largest Insider Buys in Sector

IMVT Logo
Immunovant, Inc.
NASDAQ: IMVT
$337M
BTSG Logo
BrightSpring Health Services, Inc. Common Stock
NASDAQ: BTSG
$259M
JANX Logo
Janux Therapeutics, Inc.
NASDAQ: JANX
$79M
PROK Logo
ProKidney Corp.
NASDAQ: PROK
$75M
RVMD Logo
Revolution Medicines, Inc.
NASDAQ: RVMD
$60M
ETNB Logo
89bio, Inc.
NASDAQ: ETNB
$50M

PLUR Insider Trading Activity

PLUR Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
 $00–
Sells
 $00–

Related Transactions

No records found

About Pluri Inc.

Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of …

Insider Activity of Pluri Inc.

Over the last 12 months, insiders at Pluri Inc. have bought $0 and sold $0 worth of Pluri Inc. stock.

On average, over the past 5 years, insiders at Pluri Inc. have bought $6.65M and sold $1.89M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 80,616 shares for transaction amount of $145,109 was made by Aberman Zami (director) on 2022‑02‑10.

List of Insider Buy and Sell Transactions, Pluri Inc.

2022-12-20SaleAberman Zamidirector
2,000
0.0062%
$0.97$1,940-19.19%
2022-02-10PurchaseAberman Zamidirector
80,616
0.4663%
$1.80$145,109-36.99%
2021-05-28SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
115,007
1.3749%
$3.72$427,826-32.34%
2021-05-27SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
95,885
1.137%
$3.69$353,816-31.97%
2021-05-26SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
144,678
1.7117%
$3.68$532,635-32.25%
2021-05-25SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
261,238
3.2238%
$3.84$1M-31.32%
2021-05-24SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
79,300
0.976%
$3.83$303,719-33.95%
2021-05-21SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
69,838
0.8932%
$3.98$277,955-35.17%
2021-05-03SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
23,721
0.3263%
$4.28$101,526-37.50%
2021-04-30SaleCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
166,004
2.486%
$4.66$773,579-37.03%
2020-11-30PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
20,000
0.6234%
$9.70$194,000-60.93%
2020-10-30PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
50,000
1.5281%
$9.51$475,500-54.05%
2020-10-29PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
20,000
0.5913%
$9.20$184,000-53.92%
2020-09-30PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
139,006
4.619%
$10.34$1.44M-54.65%
2020-09-29PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
60,123
1.8858%
$9.76$586,800-52.72%
2020-09-28PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
13,189
0.4022%
$9.49$125,164-49.42%
2020-09-24PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
34,800
1.0087%
$9.02$313,896-45.34%
2020-09-23PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
10,734
0.3117%
$9.04$96,983-46.14%
2020-07-31PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
14,536
0.4405%
$9.43$137,074-28.67%
2020-07-30PurchaseCLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
51,235
1.5131%
$9.19$470,850-23.58%
Total: 114

Insider Historical Profitability

<0.0001%
YANAY YAKYCo-CEO & President
4253045
60.7826%
$20.09M117+5.96%
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP10 percent owner
3121918
44.6171%
$14.75M288<0.0001%
MERETSKI SHAI10 percent owner
2400000
34.2997%
$11.34M10
Aberman Zamidirector
1491973
21.3226%
$7.05M138+1.24%
BRAUN ISAACdirector
636208
9.0924%
$3.01M10<0.0001%

Historical Insider Profitability vs. Competitors

Pluri Inc.
(PLUR)
$14,315,062
61
-6.21%
$33.06M
$53,490,060
55
19.35%
$30.29M
$1,295,471
17
21.79%
$25.73M
$17,594,514
16
-20.37%
$33.77M
$139,007,129
16
47.16%
$35.4M

PLUR Institutional Investors: Active Positions

Increased Positions10+71.43%15,815+35.29%
Decreased Positions4-28.57%3,999-8.92%
New Positions6New233New
Sold Out Positions<1Sold Out13Sold Out
Total Postitions20+42.86%56,629+26.37%

PLUR Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Renaissance Technologies Llc$157.000.49%34,025+9,400+38.17%2024-12-31
Values First Advisors, Inc.$54.000.17%11,668-2,372-16.89%2024-12-31
Ubs Group Ag$34.000.11%7,428+6,068+446.18%2024-12-31
Eversource Wealth Advisors, Llc$9.000.03%2,00000%2024-12-31
Morgan Stanley$3.000.01%585+98+20.12%2024-12-31
Wells Fargo & Company/Mn$1.00<0.01%17500%2024-12-31
Zurcher Kantonalbank (Zurich Cantonalbank)$1.00<0.01%136-1,523-91.8%2024-12-31
Citigroup Inc$1.00<0.01%125+125New2024-12-31
Royal Bank Of Canada$1.00<0.01%12500%2024-12-31
Td Waterhouse Canada Inc.$0<0.01%9300%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.